Literature DB >> 12461194

Depression and suicidal ideation in patients who discontinue the life-support treatment of dialysis.

Lewis M Cohen1, Steven K Dobscha, Kevin C Hails, Penelope S Pekow, Harvey Max Chochinov.   

Abstract

OBJECTIVE: The objective of this study was to determine the prevalence of major depression and suicidal ideation in patients who stop the life-support treatment of dialysis.
METHODS: The authors prospectively studied 79 subjects who discontinued maintenance dialysis at eight facilities in North America. Structured interviews were conducted with 23 patients and 76 families.
RESULTS: The prevalence of major depression in the sample was between 5% and 25%, and only 1 of 22 patients considered himself to have the illness of depression. Approximately 12% of the respondents were unsure or believed that discontinuing dialysis was the equivalent of suicide. This belief did not correlate with measures of depression. In comparison with the general population there seemed to be an increased prevalence of past suicide attempts.
CONCLUSIONS: Most patients who decide to stop dialysis do not seem to be influenced by major depression or ordinary suicidal ideation. Although the sample size was small, these results highlight the need to further examine the theoretical framework and terminology of depression and suicide in the context of terminal illness.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach

Mesh:

Year:  2002        PMID: 12461194     DOI: 10.1097/01.psy.0000028828.64279.84

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  8 in total

1.  Factors associated with depression and anxiety in patients with end-stage renal disease receiving maintenance hemodialysis.

Authors:  Yue Hou; Xiujiang Li; Lizhi Yang; Chang Liu; Hao Wu; Ying Xu; Fan Yang; Yujun Du
Journal:  Int Urol Nephrol       Date:  2014-03-12       Impact factor: 2.370

2.  Improving clinical skills to support the emotional and psychological well-being of patients with end-stage renal disease: a qualitative evaluation of two interventions.

Authors:  Francesca Taylor; Gill Combes; Jennifer Hare
Journal:  Clin Kidney J       Date:  2016-04-14

3.  Integrating emotional and psychological support into the end-stage renal disease pathway: a protocol for mixed methods research to identify patients' lower-level support needs and how these can most effectively be addressed.

Authors:  Francesca Taylor; Celia Taylor; Jyoti Baharani; Johann Nicholas; Gill Combes
Journal:  BMC Nephrol       Date:  2016-08-02       Impact factor: 2.388

4.  The psychological trajectory from diagnosis to approaching end of life in patients undergoing hemodialysis in China: A qualitative study.

Authors:  Hong-Yan Niu; Jin-Feng Liu
Journal:  Int J Nurs Sci       Date:  2016-12-18

5.  Evaluation of psychopathological symptoms, death anxiety, coronavirus anxiety, suicide risk, and associated risk factors among hemodialysis patients in the COVID-19 pandemic.

Authors:  Süleyman Korkut
Journal:  Ther Apher Dial       Date:  2022-07-17       Impact factor: 2.195

6.  Major depressive disorders in chronic hemodialysis patients in Nazareth: identification and assessment.

Authors:  Zaher Armaly; Joseph Farah; Adel Jabbour; Bishara Bisharat; Amir Abd-El Qader; Shahira Saba; Maha Zaher; Elia El Haj; Munir Hamzi; Abdalla Bowirrat
Journal:  Neuropsychiatr Dis Treat       Date:  2012-07-25       Impact factor: 2.570

Review 7.  Palliative dialysis: a change of perspective.

Authors:  Thiago Gomes Romano; Henrique Palomba
Journal:  J Clin Med Res       Date:  2014-05-22

8.  Dignity and Distress towards the End of Life across Four Non-Cancer Populations.

Authors:  Harvey Max Chochinov; Wendy Johnston; Susan E McClement; Thomas F Hack; Brenden Dufault; Murray Enns; Genevieve Thompson; Mike Harlos; Ronald W Damant; Clare D Ramsey; Sara Davison; James Zacharias; Doris Milke; David Strang; Heather J Campbell-Enns; Maia S Kredentser
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.